Evidence map›Paper›PMID 40795249›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2025

Immunoglobulin GM (γ marker) allotypes and their role in immune response and disease susceptibility.

Janardan P Pandey

Abstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Immunoglobulin allotypes andJournal of Alzheimer's disease : JAD · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Janardan P PandeyDepartment of Pharmacology and Immunology, Medical University of South Carolina, Charleston, SC, United States.

Funding

Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's DiseaseR01AG080451 · NIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JANARDAN P PANDEY · 2023 to 2026
$1.5M
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal KeratitisR21EY034167 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PANDEY, JANARDAN P · 2022 to 2023
$415k
IGHG Genes (GM Allotypes) and Anti-CMV (UL70) Antibody Responses as Prognostic Markers for Chronic Graft-Versus-Host-DiseaseR21HL167662 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI PANDEY, JANARDAN P · 2023 to 2024
$227k
NEI NIH HHS R21 EY034167NHLBI NIH HHS R21 HL167662NIA NIH HHS R01 AG080451NIH HHS R01AG080451NIH HHS R21EY034167NIH HHS R21HL167662U.S. Department of Defense HT9425-23-1-0504
6 · The paper itself

Abstract

Immunoglobulin GM (γ marker) allotypes are encoded by 3 very closely linked and highly homologous immunoglobulin heavy chain G (IGHG) genes-IGHG1, IGHG2, and IGHG3-on chromosome 14q32. They are localized on the constant region of γ1, γ2, and γ3 chains. There are currently 18 serologically testable GM specificities. Linkage disequilibrium in the GM system within a racial/ethnic group is almost absolute and the determinants are transmitted as haplotypes. Major racial/ethnic groups are characterized by unique arrays of several GM haplotypes. In this article, I review the basic genetics of GM allotypes, their role in antibody responses to infectious pathogens and vaccines, their contribution to Fc-mediated effector functions, and their potential role in immunotherapy. Additionally, I discuss the association of GM allotypes with many autoimmune, infectious, and malignant diseases.

Indexed as

Genetic Predisposition to DiseaseImmunoglobulin Gm AllotypesAnimalsAutoimmune DiseasesDisease SusceptibilityHumansImmunoglobulin Gm AllotypesADCCFcRnGM allotypesimmune responseimmunoevasion

Identifiers

PMID40795249
PMCPMC12726066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.